2021-01125. Requests for Proposals for Insulin Reimportation and Personal Prescription Drug Importation
-
Start Preamble
AGENCY:
Department of Health and Human Services (HHS), Food and Drug Administration (FDA).
ACTION:
Notice; requests for proposals.
SUMMARY:
On September 24, 2020, the Department issued two requests for proposals for the reimportation of insulin and the personal importation of prescription drugs on its website. The Department is issuing this Notice to include a revised version of the September 24, 2020 proposals in the Federal Register.
DATES:
Proposals submitted in response to the requests for proposals shall be accepted and reviewed on a rolling basis, and until further notice.
ADDRESSES:
Responses to the requests for proposals should be submitted to import@hhs.gov.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Nick Uehlecke, 200 Independence Ave SW, Washington, DC 20201; or by email at import@hhs.gov; or by telephone at 1-877-696-6775.
End Further Info End Preamble Start Supplemental Information Start Printed Page 6344SUPPLEMENTARY INFORMATION:
On September 24, 2020, the Department issued two requests for proposals for the reimportation of insulin and the personal importation of prescription drugs on its website. The proposals were issued consistent with FDA's authorities under sections 801 and 804 of the Food, Drug, and Cosmetic Act, 21 U.S.C. 381, 384. The Department is issuing this Notice to include revised versions of these proposals in the Federal Register.
Start SignatureDated: January 13, 2021.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2021-01125 Filed 1-19-21; 8:45 am]
BILLING CODE 4150-26-P
Document Information
- Published:
- 01/21/2021
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice; requests for proposals.
- Document Number:
- 2021-01125
- Dates:
- Proposals submitted in response to the requests for proposals shall be accepted and reviewed on a rolling basis, and until further notice.
- Pages:
- 6343-6344 (2 pages)
- PDF File:
- 2021-01125.pdf
- Supporting Documents:
- » Securing Updated and Necessary Statutory Evaluations Timely; Proposal To Withdraw or Repeal
- » Medical Devices; Class I Surgeon’s and Patient Examination Gloves
- » Requests for Proposals for Insulin Reimportation and Personal Prescription Drug Importation; Withdrawal
- » Withdrawal of Notice Regarding the Food and Drug Administration Drug Review Timeline Transparency; Revocation of Statement of Policy
- » Medical Devices; Class I Surgeon’s and Patient Examination Glove
- » Making Permanent Regulatory Flexibilities Provided During the COVID–19 Public Health Emergency by Exempting Certain Medical Devices From Premarket Notification Requirements; Withdrawal of Proposed Exemptions
- » Requests for Proposals for Insulin Reimportation and Personal Prescription Drug Importation
- » Securing Updated and Necessary Statutory Evaluations Timely